Literature DB >> 30158571

Gut microbiome, microbial metabolites and the development of NAFLD.

Cyrielle Caussy1,2, Rohit Loomba3,4,5.   

Abstract

Entities:  

Mesh：

Year:  2018        PMID： 30158571     DOI： 10.1038/s41575-018-0058-x

Source DB:  PubMed          Journal:  Nat Rev Gastroenterol Hepatol        ISSN： 1759-5045            Impact factor:   46.802


× No keyword cloud information.
  14 in total

Review 1.  Metabolomics and lipidomics in NAFLD: biomarkers and non-invasive diagnostic tests.

Authors:  Mojgan Masoodi; Amalia Gastaldelli; Tuulia Hyötyläinen; Enara Arretxe; Cristina Alonso; Melania Gaggini; Julia Brosnan; Quentin M Anstee; Oscar Millet; Pablo Ortiz; Jose M Mato; Jean-Francois Dufour; Matej Orešič
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2021-09-10       Impact factor: 46.802

2.  A gut microbiome signature for cirrhosis due to nonalcoholic fatty liver disease.

Authors:  Cyrielle Caussy; Anupriya Tripathi; Greg Humphrey; Shirin Bassirian; Seema Singh; Claire Faulkner; Ricki Bettencourt; Emily Rizo; Lisa Richards; Zhenjiang Z Xu; Michael R Downes; Ronald M Evans; David A Brenner; Claude B Sirlin; Rob Knight; Rohit Loomba
Journal:  Nat Commun       Date:  2019-03-29       Impact factor: 14.919

Review 3.  Antioxidant Versus Pro-Apoptotic Effects of Mushroom-Enriched Diets on Mitochondria in Liver Disease.

Authors:  Adriana Fontes; Mireia Alemany-Pagès; Paulo J Oliveira; João Ramalho-Santos; Hans Zischka; Anabela Marisa Azul
Journal:  Int J Mol Sci       Date:  2019-08-16       Impact factor: 5.923

4.  Gut Microbiota Dysbiosis Is Associated with Altered Bile Acid Metabolism in Infantile Cholestasis.

Authors:  Yizhong Wang; Xuefeng Gao; Xinyue Zhang; Yongmei Xiao; Jiandong Huang; Dongbao Yu; Xiaolu Li; Hui Hu; Ting Ge; Dan Li; Ting Zhang
Journal:  mSystems       Date:  2019-12-17       Impact factor: 6.496

5.  Gut microbiota impact on the peripheral immune response in non-alcoholic fatty liver disease related hepatocellular carcinoma.

Authors:  Jason Behary; Nadia Amorim; Xiao-Tao Jiang; Anita Raposo; Lan Gong; Emily McGovern; Ragy Ibrahim; Francis Chu; Carlie Stephens; Hazem Jebeili; Vincenzo Fragomeli; Yen Chin Koay; Miriam Jackson; John O'Sullivan; Martin Weltman; Geoffrey McCaughan; Emad El-Omar; Amany Zekry
Journal:  Nat Commun       Date:  2021-01-08       Impact factor: 14.919

Review 6.  Promising diagnostic biomarkers of nonalcoholic fatty liver disease and nonalcoholic steatohepatitis: From clinical proteomics to microbiome.

Authors:  Carolina Castillo-Castro; Alexandro José Martagón-Rosado; Rocio Ortiz-Lopez; Luis Felipe Garrido-Treviño; Melissa Villegas-Albo; Francisco Javier Bosques-Padilla
Journal:  World J Hepatol       Date:  2021-11-27

7.  Alterations in bile acid metabolizing gut microbiota and specific bile acid genes as a precision medicine to subclassify NAFLD.

Authors:  Na Jiao; Rohit Loomba; Zi-Huan Yang; Dingfeng Wu; Sa Fang; Richele Bettencourt; Ping Lan; Ruixin Zhu; Lixin Zhu
Journal:  Physiol Genomics       Date:  2021-06-21       Impact factor: 4.297

8.  Associations between Helicobacter pylori with nonalcoholic fatty liver disease and other metabolic conditions in Guatemala.

Authors:  Christian S Alvarez; Andrea A Florio; Julia Butt; Alvaro Rivera-Andrade; María F Kroker-Lobos; Tim Waterboer; Maria Constanza Camargo; Neal D Freedman; Barry I Graubard; Mariana Lazo; Eliseo Guallar; John D Groopman; Manuel Ramírez-Zea; Katherine A McGlynn
Journal:  Helicobacter       Date:  2020-10-02       Impact factor: 5.182

9.  Polysaccharides isolated from Cordyceps Sinensis contribute to the progression of NASH by modifying the gut microbiota in mice fed a high-fat diet.

Authors:  Lei Chen; Liangyu Zhang; Wendong Wang; Wei Qiu; Lei Liu; Anhong Ning; Jing Cao; Min Huang; Mintao Zhong
Journal:  PLoS One       Date:  2020-06-08       Impact factor: 3.240

10.  The Commensal Microbe Veillonella as a Marker for Response to an FGF19 Analog in NASH.

Authors:  Rohit Loomba; Lei Ling; Duy M Dinh; Alex M DePaoli; Hsiao D Lieu; Stephen A Harrison; Arun J Sanyal
Journal:  Hepatology       Date:  2020-12-11       Impact factor: 17.425
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.